Skip to main content
Top
Published in: Endocrine 2/2017

Open Access 01-02-2017 | Original Article

Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control

Authors: Katarzyna Cyganek, Jan Skupien, Barbara Katra, Alicja Hebda-Szydlo, Izabela Janas, Iwona Trznadel-Morawska, Przemysław Witek, Elżbieta Kozek, Maciej T. Malecki

Published in: Endocrine | Issue 2/2017

Login to get access

Abstract

Macrosomia risk remains high in type 1 diabetes (T1DM) complicated pregnancies. A linear relationship between macrosomia risk and glycated hemoglobin A1c (HbA1c) was described; however, low range of HbA1c has not been studied. We aimed to identify risk factors and examine the impact of HbA1c on the occurrence of macrosomia in newborns of T1DM women from a cohort with good glycemic control. In this observational retrospective one-center study we analyzed records of 510 consecutive T1DM pregnancies (1998–2012). The analyzed group consisted of 375 term singleton pregnancies. We used multiple regression models to examine the impact of HbA1c and self-monitored glucose in each trimester on the risk of macrosomia and birth weight. The median age of T1DM women was 28 years, median T1DM duration—11 years, median pregestational BMI—23.3 kg/m2. Median birth weight reached 3520 g (1st and 3rd quartiles 3150 and 3960, respectively) at median 39 weeks of gestation. There were 85 (22.7 %) macrosomic (>4000 g) newborns. Median HbA1c levels in the 1st, 2nd, and 3rd trimester were 6.4, 5.7, and 5.6 %. Third trimester HbA1c, mean fasting self-monitored glucose and maternal age were independent predictors of birth weight and macrosomia. There was a linear relationship between 3rd trimester HbA1c and macrosomia risk in HbA1c range from 4.5 to 7.0 %. Macrosomia in children of T1DM mothers was common despite excellent metabolic control. Glycemia during the 3rd trimester was predominantly responsible for this condition.
Literature
1.
go back to reference G. Danaei, M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, M. Ezzati; on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose), National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378, 31–40 (2011)CrossRefPubMed G. Danaei, M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, M. Ezzati; on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose), National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378, 31–40 (2011)CrossRefPubMed
2.
go back to reference R. Bell, K. Bailey, T. Cresswell, G. Hawthorne, J. Critchley, N. Lewis-Barned; Northern Diabetic Pregnancy Survey Steering Group, Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 115, 445–452 (2008)CrossRefPubMed R. Bell, K. Bailey, T. Cresswell, G. Hawthorne, J. Critchley, N. Lewis-Barned; Northern Diabetic Pregnancy Survey Steering Group, Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 115, 445–452 (2008)CrossRefPubMed
3.
go back to reference DCCT Investigators, Pregnancy outcomes in the diabetes control and complications trial. AJOG 174, 1343–1353 (1996)CrossRef DCCT Investigators, Pregnancy outcomes in the diabetes control and complications trial. AJOG 174, 1343–1353 (1996)CrossRef
4.
go back to reference M. Balsells, A. García-Patterson, I. Gich, R.N. Corcoy, Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. JCEM 94, 4284–4291 (2009)PubMed M. Balsells, A. García-Patterson, I. Gich, R.N. Corcoy, Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. JCEM 94, 4284–4291 (2009)PubMed
5.
go back to reference I. Evers, H. de Valk, B. Mol, E. ter Braak, G. Visser, Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 45, 1484–1489 (2002)CrossRefPubMed I. Evers, H. de Valk, B. Mol, E. ter Braak, G. Visser, Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 45, 1484–1489 (2002)CrossRefPubMed
6.
go back to reference L. Suhonen, V. Hiilesmaa, K. Teramo, Glycaemic control during early pregnancy and fetal malfomations in women with type 1 diabetes mellitus. Diabetologia 43, 79–84 (2000)CrossRefPubMed L. Suhonen, V. Hiilesmaa, K. Teramo, Glycaemic control during early pregnancy and fetal malfomations in women with type 1 diabetes mellitus. Diabetologia 43, 79–84 (2000)CrossRefPubMed
7.
go back to reference Diabetes and Pregnancy Group, France, French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26, 2990–2993 (2003)CrossRef Diabetes and Pregnancy Group, France, French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26, 2990–2993 (2003)CrossRef
8.
go back to reference R.C. Temple, V. Aldridge, H.R. Murphy, Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 29, 1744–1749 (2006)CrossRefPubMed R.C. Temple, V. Aldridge, H.R. Murphy, Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 29, 1744–1749 (2006)CrossRefPubMed
9.
go back to reference D.F. Lewis, M.S. Edwards, T. Asrat, C.D. Adair, G. Brooks, S.J. London, Can shoulder dystocia be predicted? Preconceptive and prenatal factors. J. Reprod. Med. 43, 654–658 (1998)PubMed D.F. Lewis, M.S. Edwards, T. Asrat, C.D. Adair, G. Brooks, S.J. London, Can shoulder dystocia be predicted? Preconceptive and prenatal factors. J. Reprod. Med. 43, 654–658 (1998)PubMed
10.
go back to reference M.A. Berk, F. Mimouni, M. Miodovnik, V. Hertzberg, J. Valuck, Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics 83, 1029–1034 (1989)PubMed M.A. Berk, F. Mimouni, M. Miodovnik, V. Hertzberg, J. Valuck, Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics 83, 1029–1034 (1989)PubMed
11.
go back to reference J.L. Ballard, B. Rosenn, J.C. Khoury, M. Miodovnik, Diabetic fetal macrosomia: significance of disproportionate growth. J Pediatrics 122, 115–119 (1993)CrossRef J.L. Ballard, B. Rosenn, J.C. Khoury, M. Miodovnik, Diabetic fetal macrosomia: significance of disproportionate growth. J Pediatrics 122, 115–119 (1993)CrossRef
12.
go back to reference M. Rijpert, I.M. Evers, M.A. de Vroede, H.W. de Valk, C.J. Heijnen, G.H. Visser, Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands. Diabetes Care 32, 2099–2104 (2009)CrossRefPubMedPubMedCentral M. Rijpert, I.M. Evers, M.A. de Vroede, H.W. de Valk, C.J. Heijnen, G.H. Visser, Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands. Diabetes Care 32, 2099–2104 (2009)CrossRefPubMedPubMedCentral
13.
go back to reference P.A. Weiss, H.S. Scholz, J. Haas, K.F. Tamussino, J. Seissler, M.H. Borkenstein, Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 23, 905–911 (2000)CrossRefPubMed P.A. Weiss, H.S. Scholz, J. Haas, K.F. Tamussino, J. Seissler, M.H. Borkenstein, Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 23, 905–911 (2000)CrossRefPubMed
14.
go back to reference The HAPO Study Cooperative Research Group, Hyperglycemia and adverse pregnancy outcomes. NEJM 358, 1991–2002 (2008)CrossRef The HAPO Study Cooperative Research Group, Hyperglycemia and adverse pregnancy outcomes. NEJM 358, 1991–2002 (2008)CrossRef
15.
go back to reference M.B. Landon, C.Y. Spong, E. Thom, M.W. Carpenter, S.M. Ramin, B. Casey, National institute of child health and human development maternal-fetal medicine units network. A multicenter, randomized trial of treatment for mild gestational diabetes. NEJM 361, 1339–1348 (2009)CrossRefPubMedPubMedCentral M.B. Landon, C.Y. Spong, E. Thom, M.W. Carpenter, S.M. Ramin, B. Casey, National institute of child health and human development maternal-fetal medicine units network. A multicenter, randomized trial of treatment for mild gestational diabetes. NEJM 361, 1339–1348 (2009)CrossRefPubMedPubMedCentral
16.
go back to reference NICE guideline. National Institute for Health and Care Excellence (2015), Diabetes in pregnancy: management Diabetes in pregnancy: management from preconception to the postnatal from preconception to the postnatal period. https://www.nice.org.uk/guidance/ng3. Accessed 25 February 2015 NICE guideline. National Institute for Health and Care Excellence (2015), Diabetes in pregnancy: management Diabetes in pregnancy: management from preconception to the postnatal from preconception to the postnatal period. https://​www.​nice.​org.​uk/​guidance/​ng3. Accessed 25 February 2015
17.
go back to reference American Diabetes Association. Standards of medical care in diabetes – 2015. Diabetes Care 38, S1–S93 (2015) American Diabetes Association. Standards of medical care in diabetes – 2015. Diabetes Care 38, S1–S93 (2015)
18.
go back to reference K. Cyganek, A. Hebda-Szydlo, B. Katra, J. Skupien, T. Klupa, I. Janas, I. Kaim, J. Sieradzki, A. Reron, M.T. Malecki, Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol. Ther. 12, 41–47 (2010)CrossRefPubMed K. Cyganek, A. Hebda-Szydlo, B. Katra, J. Skupien, T. Klupa, I. Janas, I. Kaim, J. Sieradzki, A. Reron, M.T. Malecki, Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol. Ther. 12, 41–47 (2010)CrossRefPubMed
19.
go back to reference Polish Diabetes Association, The clinical guidelines in patients with diabetes. Diabet. Prakt. 10, A29–A33 (2009) Polish Diabetes Association, The clinical guidelines in patients with diabetes. Diabet. Prakt. 10, A29–A33 (2009)
20.
go back to reference Kidney Disease Improving Global Outcomes. KDIGO, Clinical practice guideline for the evaluation and management of chronic kidney disease: Chapter 2: Definition, identification, and prediction of CKD progression. Kidney Int. Suppl. 3, 63–72 (2013)CrossRef Kidney Disease Improving Global Outcomes. KDIGO, Clinical practice guideline for the evaluation and management of chronic kidney disease: Chapter 2: Definition, identification, and prediction of CKD progression. Kidney Int. Suppl. 3, 63–72 (2013)CrossRef
23.
go back to reference S.V. Glinianaia, P.W. Tennant, R.W. Bilous, J. Rankin, R. Bell, HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia 55, 3193–3203 (2012)CrossRefPubMed S.V. Glinianaia, P.W. Tennant, R.W. Bilous, J. Rankin, R. Bell, HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia 55, 3193–3203 (2012)CrossRefPubMed
24.
go back to reference F.D. Johnstone, R.S. Lindsay, J. Steel, Type 1 diabetes and pregnancy: trends in birth weight over 40 years at a single clinic. Obstet. Gynecol. 107, 1297–1302 (2006)CrossRefPubMed F.D. Johnstone, R.S. Lindsay, J. Steel, Type 1 diabetes and pregnancy: trends in birth weight over 40 years at a single clinic. Obstet. Gynecol. 107, 1297–1302 (2006)CrossRefPubMed
25.
go back to reference D. Kernaghan, G.C. Penney, D.W. Pearson; Scottish Diabetes in Pregnancy Study Group, Birth weight and maternal glycated haemoglobin in pregnancies complicated by type 1 diabetes. Scott. Med. J. 52, 9–12 (2007)CrossRefPubMed D. Kernaghan, G.C. Penney, D.W. Pearson; Scottish Diabetes in Pregnancy Study Group, Birth weight and maternal glycated haemoglobin in pregnancies complicated by type 1 diabetes. Scott. Med. J. 52, 9–12 (2007)CrossRefPubMed
26.
go back to reference M. Klementti, NuutilaM, M. Tikkanen, M.A. Kari, V. Hiilesmaa, K. Teramo, Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989–2008. Diabetologia 5, 2327–2334 (2012)CrossRef M. Klementti, NuutilaM, M. Tikkanen, M.A. Kari, V. Hiilesmaa, K. Teramo, Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989–2008. Diabetologia 5, 2327–2334 (2012)CrossRef
27.
go back to reference F.P. Dunne, G. Avalos, M. Durkan, Y. Mitchell, T. Gallacher, M. Keenan, M. Hogan, L.A. Carmody, G. Gaffnej; for the ATLANTIC DIP Collaborators, ATLANTIC DIP: Pregnancy outcome for women with pregestational diabetes along the irish atlantic seaboard. Diabetes Care 32, 1205–1206 (2009)CrossRefPubMedPubMedCentral F.P. Dunne, G. Avalos, M. Durkan, Y. Mitchell, T. Gallacher, M. Keenan, M. Hogan, L.A. Carmody, G. Gaffnej; for the ATLANTIC DIP Collaborators, ATLANTIC DIP: Pregnancy outcome for women with pregestational diabetes along the irish atlantic seaboard. Diabetes Care 32, 1205–1206 (2009)CrossRefPubMedPubMedCentral
28.
go back to reference L.A. Owens, G. Avalos, B. Kirwan, L. Carmody, F. Dunne; ATLANTIC DIP: closing the Loop, A change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care 35, 1669–1671 (2012)CrossRefPubMedPubMedCentral L.A. Owens, G. Avalos, B. Kirwan, L. Carmody, F. Dunne; ATLANTIC DIP: closing the Loop, A change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care 35, 1669–1671 (2012)CrossRefPubMedPubMedCentral
29.
go back to reference M.J. Maresh, V.A. Holmes, C.C. Patterson, I.S. Young, D.W. Pearson, J.D. Walker, D.R. McCance; Diabetes and Pre-eclampsia Intervention Trial Study Group, Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care 38, 34–42 (2015)CrossRefPubMed M.J. Maresh, V.A. Holmes, C.C. Patterson, I.S. Young, D.W. Pearson, J.D. Walker, D.R. McCance; Diabetes and Pre-eclampsia Intervention Trial Study Group, Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care 38, 34–42 (2015)CrossRefPubMed
30.
go back to reference M.J. O’Kane, P.L. Lynch, K.W. Moles, S.E. Magee, Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin. Chim. Acta 311, 157–159 (2001)CrossRefPubMed M.J. O’Kane, P.L. Lynch, K.W. Moles, S.E. Magee, Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin. Chim. Acta 311, 157–159 (2001)CrossRefPubMed
31.
go back to reference N. Nowak, J. Skupien, K. Cyganek, B. Matejko, M.T. Malecki, 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia 56, 709–713 (2013)CrossRefPubMedPubMedCentral N. Nowak, J. Skupien, K. Cyganek, B. Matejko, M.T. Malecki, 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia 56, 709–713 (2013)CrossRefPubMedPubMedCentral
Metadata
Title
Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control
Authors
Katarzyna Cyganek
Jan Skupien
Barbara Katra
Alicja Hebda-Szydlo
Izabela Janas
Iwona Trznadel-Morawska
Przemysław Witek
Elżbieta Kozek
Maciej T. Malecki
Publication date
01-02-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1134-z

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue